Industry News
Therapy targeting BRAFV600E mutation could inhibit aggressive growth of melanoma tumors
Sep 16, 2014
Dartmouth researchers have found that the genetic mutation BRAFV600E , frequently found in metastatic melanoma, not only secretes a protein that promotes the growth of melanoma tumor cells, but can... Read More
New cellular connection makes scientific history
Sep 16, 2014
Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection. Read More
Patient profiling may lead to earlier transition from active treatment to hospice care
Sep 16, 2014
One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania. Read More
Breast cancer screening in over-70s 'may lead to overdiagnosis'
Sep 16, 2014
A study analyzing breast screening for older women in the Netherlands found that the program did not produce the expected sharp fall in cases of advanced disease in this group. Read More
African American women 55 percent less likely to have breast reconstruction after mastectomy
Sep 16, 2014
Dartmouth researchers have found that African American women receive less breast reconstruction after mastectomy regardless of where they received their care. Read More
Promising results for one-minute point-of-care anemia test
Sep 16, 2014
A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the... Read More
Patients with head and neck cancers resistant to cetuximab may benefit from an investigational drug
Sep 15, 2014
The investigational drug alpelisib, previously known as BYL719, was able to overcome head and neck cancer resistance to the anti-EGFR treatment cetuximab, and combining alpelisib with cetuximab was... Read More
Killing leukemia cells by disrupting their metabolism doesn't harm normal cells
Sep 15, 2014
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. Read More
Genetic testing can identify men at six-fold increased risk of prostate cancer
Sep 15, 2014
Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. Read More
Merck discontinues clinical development program of tecemotide as a monotherapy in Stage III non-small cell lung cancer
Sep 15, 2014
Merck has announced that its biopharmaceutical division Merck Serono will discontinue the clinical development program of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide... Read More
Previous Page Next Page